These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12624800)

  • 1. [The rheumatologist's conflict between "off-label" prescription and failure to render assistance].
    Hellmich B; Gross WL
    Z Rheumatol; 2003 Feb; 62(1):34-5. PubMed ID: 12624800
    [No Abstract]   [Full Text] [Related]  

  • 2. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv
    Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Solutions for off-label therapy].
    Schmidt WA
    Z Rheumatol; 2003; 62(Suppl 2):II54-6. PubMed ID: 14648094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leflunomide and TNF inhibitors. Experiences from precription recourse proceedings].
    Brandt-Jürgens J
    Z Rheumatol; 2013 Mar; 72(2):114-6. PubMed ID: 23223912
    [No Abstract]   [Full Text] [Related]  

  • 5. [Off-label therapy of rheumatoid arthritis and spondyloarthritis].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):122-4, 126. PubMed ID: 22370803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. My prior authorization nightmare.
    Smith CF
    Minn Med; 2016; 99(2):22-5. PubMed ID: 27089670
    [No Abstract]   [Full Text] [Related]  

  • 7. [Off-label use of drugs--the legal framework].
    Koyuncu A
    Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
    [No Abstract]   [Full Text] [Related]  

  • 8. NICE and new drugs for rheumatoid arthritis.
    Lancet; 2008 May; 371(9623):1477. PubMed ID: 18456081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Authorization and reimbursement of orphan drugs in an international comparison].
    Roll K; Stargardt T; Schreyögg J
    Gesundheitswesen; 2011 Aug; 73(8-9):504-14. PubMed ID: 20848380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Off-label use in oncology: an inexhaustible topic?!].
    Weissbach L; Riese J
    Urologe A; 2006 Nov; 45(11):1410, 1412-4. PubMed ID: 17043888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of biosimilars medicines for private and statutory health insurance].
    Bretthauer B
    Versicherungsmedizin; 2016 Dec; 68(4):173-5. PubMed ID: 29144116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does red-green destroy phytotherapy?].
    Krankenpfl J; 2003; 41(4-6):111. PubMed ID: 12929322
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.
    Darmawan J; Rasker JJ; Nuralim H
    J Rheumatol Suppl; 2004 Mar; 69():66-9. PubMed ID: 15053456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health insurance oversight issue brief: mandated benefits: off-label drug coverage requirements: year end report--2004.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15726733
    [No Abstract]   [Full Text] [Related]  

  • 15. [Off-label therapy in rheumatology].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):99-100. PubMed ID: 22370799
    [No Abstract]   [Full Text] [Related]  

  • 16. Finance issue brief: mandated benefits: off-label drug coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-9. PubMed ID: 14870745
    [No Abstract]   [Full Text] [Related]  

  • 17. [New drugs must henceforth be better than the current standard. What remains for physician therapy autonomy?].
    Schmidt K
    MMW Fortschr Med; 2006 Dec; 148(49-50):61, 63. PubMed ID: 17619334
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 19. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. We need to fix PA now.
    Wood D
    Minn Med; 2015 Mar; 98(3):30. PubMed ID: 25876319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.